Pilot Study for Non-invasive Glioma Characterization Through Molecular Imaging
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adults (≥18 year old)
• Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion.
Locations
United States
Florida
University of Miami
RECRUITING
Miami
Contact Information
Primary
Nathalie Padron
npadron@med.miami.edu
305-243-3530
Time Frame
Start Date: 2019-01-25
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 30
Treatments
Experimental: IDH-Mutant Glioma Patients
Patients who have suspected or confirmed gliomas and are scheduled to undergo biopsy or resection of their brain tumors will receive a 3 Tesla (3T) Magnetic Resonance Imaging (MRI) scan of their brain.
Related Therapeutic Areas
Sponsors
Leads: University of Miami